The Asia Pacific Drug Eluting Stent Market would witness market growth of 9.4% CAGR during the forecast period (2023-2030). In the year 2021, the Asia Pacific market's volume surged to 2,665.7 thousand units, showcasing a growth of 9.3% (2019-2022).
The production process uses a range of coating procedures, each of which has benefits and drawbacks that need to be taken into consideration when selecting which to apply. The primary coating methods used in DES include direct-write inkjet technique, electrospinning, dip coating, and spray coating. In the spray-coating method, solution-forming droplets containing the polymer (and a medication) are sprayed using a nozzle on a rotating setting. The stent is submerged into a polymer-drug solution numerous times using dip-coating.
A proper number of drugs is thus released after a few repetitions. This method has the benefits of being straightforward and inexpensive, and it is often utilized for research. Contrarily, the direct-write inkjet technology, which is considerably superior to the spray-coating and dip-coating methods, demonstrates several benefits, including flexibility, cheap cost, and high coating yields by managing sample suction from the dispenser nozzle. The direct-write inkjet technology works by printing polymer particles that have been drugged directly onto the metal surface.
Additionally, this method allows for highly exact tuning of the polymer-drug droplet size. It simultaneously patterns numerous analytes using separate cartridges, reduces coating material contamination, and supports medication release profiles. The applied voltage is used in electrospinning to atomize liquid particles. Monodispersed highly charged tiny, atomized droplets provide highly effective polymer deposition onto substrates. This method is entirely novel and even produces polymeric scaffolds with mechanically similar characteristics to actual vascular tissue.
In India, the primary cause of death is cardiovascular disease (CVD), including ischemic heart disease and cerebrovascular conditions like stroke. As per the World Health Organization, India is responsible for one-fifth of these global deaths, particularly among the younger population. In accordance with the Global Burden of Disease study findings, India has an age-standardized CVD death rate of 272 per 100,000 people, significantly higher than the global average of 235. High familial incidence of coronary artery disease suggests a potential genetic connection. Numerous studies indicate the existence of particular "candidate genes" linked to coronary heart disease pathways. These factors will help generate more demand for the drug eluting stents in the Asia-Pacific region.
The China market dominated the Asia Pacific Drug Eluting Stent Market by Country in 2022 and would continue to be a dominant market till 2030; thereby, achieving a market value of $930 million by 2030. The Japan market is registering a CAGR of 8.7% during (2023 - 2030). Additionally, The India market would showcase a CAGR of 10.1% during (2023 - 2030).
Based on Application, the market is segmented into Coronary Artery Disease, and Peripheral Artery Disease. Based on Coating Type, the market is segmented into Polymer-based Coating (Non-biodegradable Polymers, and Biodegradable Polymers), and Polymer-free Coating (Micro Porous Surface, Micro Structured Surface, Slotted Tubular Surface, and Nanoporous Surface). Based on countries, the market is segmented into China, Japan, India, South Korea, Singapore, Malaysia, and Rest of Asia Pacific.
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Abbott Laboratories, Boston Scientific Corporation, Terumo Corporation, Medtronic PLC, Biosensors International Group, Ltd. (Blue Sail Medical Co., Ltd.), Cook Medical, Inc. (Cook Group), B. Braun Melsungen AG, Biotronik SE & Co. KG, Lepu Medical Technology Co., Ltd and Alvimedica.
The production process uses a range of coating procedures, each of which has benefits and drawbacks that need to be taken into consideration when selecting which to apply. The primary coating methods used in DES include direct-write inkjet technique, electrospinning, dip coating, and spray coating. In the spray-coating method, solution-forming droplets containing the polymer (and a medication) are sprayed using a nozzle on a rotating setting. The stent is submerged into a polymer-drug solution numerous times using dip-coating.
A proper number of drugs is thus released after a few repetitions. This method has the benefits of being straightforward and inexpensive, and it is often utilized for research. Contrarily, the direct-write inkjet technology, which is considerably superior to the spray-coating and dip-coating methods, demonstrates several benefits, including flexibility, cheap cost, and high coating yields by managing sample suction from the dispenser nozzle. The direct-write inkjet technology works by printing polymer particles that have been drugged directly onto the metal surface.
Additionally, this method allows for highly exact tuning of the polymer-drug droplet size. It simultaneously patterns numerous analytes using separate cartridges, reduces coating material contamination, and supports medication release profiles. The applied voltage is used in electrospinning to atomize liquid particles. Monodispersed highly charged tiny, atomized droplets provide highly effective polymer deposition onto substrates. This method is entirely novel and even produces polymeric scaffolds with mechanically similar characteristics to actual vascular tissue.
In India, the primary cause of death is cardiovascular disease (CVD), including ischemic heart disease and cerebrovascular conditions like stroke. As per the World Health Organization, India is responsible for one-fifth of these global deaths, particularly among the younger population. In accordance with the Global Burden of Disease study findings, India has an age-standardized CVD death rate of 272 per 100,000 people, significantly higher than the global average of 235. High familial incidence of coronary artery disease suggests a potential genetic connection. Numerous studies indicate the existence of particular "candidate genes" linked to coronary heart disease pathways. These factors will help generate more demand for the drug eluting stents in the Asia-Pacific region.
The China market dominated the Asia Pacific Drug Eluting Stent Market by Country in 2022 and would continue to be a dominant market till 2030; thereby, achieving a market value of $930 million by 2030. The Japan market is registering a CAGR of 8.7% during (2023 - 2030). Additionally, The India market would showcase a CAGR of 10.1% during (2023 - 2030).
Based on Application, the market is segmented into Coronary Artery Disease, and Peripheral Artery Disease. Based on Coating Type, the market is segmented into Polymer-based Coating (Non-biodegradable Polymers, and Biodegradable Polymers), and Polymer-free Coating (Micro Porous Surface, Micro Structured Surface, Slotted Tubular Surface, and Nanoporous Surface). Based on countries, the market is segmented into China, Japan, India, South Korea, Singapore, Malaysia, and Rest of Asia Pacific.
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Abbott Laboratories, Boston Scientific Corporation, Terumo Corporation, Medtronic PLC, Biosensors International Group, Ltd. (Blue Sail Medical Co., Ltd.), Cook Medical, Inc. (Cook Group), B. Braun Melsungen AG, Biotronik SE & Co. KG, Lepu Medical Technology Co., Ltd and Alvimedica.
Scope of the Study
Market Segments Covered in the Report:
By Application (Volume, Thousand Units, USD Million, 2019-2030)- Coronary Artery Disease
- Peripheral Artery Disease
- Polymer-based Coating
- Non-biodegradable Polymers
- Biodegradable Polymers
- Polymer-free Coating
- Micro Porous Surface
- Micro Structured Surface
- Slotted Tubular Surface
- Nanoporous Surface
- China
- Japan
- India
- South Korea
- Singapore
- Malaysia
- Rest of Asia Pacific
Key Market Players
List of Companies Profiled in the Report:
- Abbott Laboratories
- Boston Scientific Corporation
- Terumo Corporation
- Medtronic PLC
- Biosensors International Group, Ltd. (Blue Sail Medical Co., Ltd.)
- Cook Medical, Inc. (Cook Group)
- B. Braun Melsungen AG
- Biotronik SE & Co. KG
- Lepu Medical Technology Co., Ltd
- Alvimedica
Unique Offerings
- Exhaustive coverage
- The highest number of Market tables and figures
- Subscription-based model available
- Guaranteed best price
- Assured post sales research support with 10% customization free
Table of Contents
Chapter 1. Market Scope & Methodology
Chapter 2. Market At a Glance
Chapter 3. Market Overview
Chapter 4. Asia Pacific Drug Eluting Stent Market by Application
Chapter 5. Asia Pacific Drug Eluting Stent Market by Coating Type
Chapter 6. Asia Pacific Drug Eluting Stent Market by Country
Chapter 7. Company Profiles
Companies Mentioned
- Abbott Laboratories
- Boston Scientific Corporation
- Terumo Corporation
- Medtronic PLC
- Biosensors International Group, Ltd. (Blue Sail Medical Co., Ltd.)
- Cook Medical, Inc. (Cook Group)
- B. Braun Melsungen AG
- Biotronik SE & Co. KG
- Lepu Medical Technology Co., Ltd
- Alvimedica
Methodology
LOADING...
